Research and development of protein-based therapeutics

Pipeline

Affibody has a broad pipeline with the most advanced projects in clinical studies. The pipeline is designed to demonstrate the value and versatility of the Affibody® technology.

Affibody in short

Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.

Upcoming reports Financial calendar

  • Year-end report (February 24, 2017)